Harpswell Capital Advisors LLC Invests $1.68 Million in SPDR S&P Biotech ETF $XBI

Harpswell Capital Advisors LLC purchased a new position in SPDR S&P Biotech ETF (NYSEARCA:XBI) in the third quarter, HoldingsChannel reports. The firm purchased 16,768 shares of the exchange traded fund’s stock, valued at approximately $1,680,000. SPDR S&P Biotech ETF accounts for 1.6% of Harpswell Capital Advisors LLC’s portfolio, making the stock its 10th largest position.

Other institutional investors and hedge funds have also recently modified their holdings of the company. JPMorgan Chase & Co. increased its position in shares of SPDR S&P Biotech ETF by 2.6% during the 2nd quarter. JPMorgan Chase & Co. now owns 10,638,105 shares of the exchange traded fund’s stock valued at $882,218,000 after purchasing an additional 268,399 shares during the last quarter. Bessemer Group Inc. raised its holdings in SPDR S&P Biotech ETF by 9.3% in the third quarter. Bessemer Group Inc. now owns 1,632,988 shares of the exchange traded fund’s stock worth $163,624,000 after purchasing an additional 138,322 shares in the last quarter. Ameriprise Financial Inc. increased its position in shares of SPDR S&P Biotech ETF by 123.0% during the second quarter. Ameriprise Financial Inc. now owns 872,796 shares of the exchange traded fund’s stock worth $72,542,000 after purchasing an additional 481,408 shares in the last quarter. Meitav Investment House Ltd. increased its holdings in shares of SPDR S&P Biotech ETF by 70.3% during the third quarter. Meitav Investment House Ltd. now owns 682,056 shares of the exchange traded fund’s stock valued at $68,156,000 after acquiring an additional 281,602 shares in the last quarter. Finally, Greenhouse Funds LLLP raised its stake in SPDR S&P Biotech ETF by 17.3% in the 2nd quarter. Greenhouse Funds LLLP now owns 579,667 shares of the exchange traded fund’s stock worth $48,072,000 after acquiring an additional 85,422 shares during the last quarter.

SPDR S&P Biotech ETF Price Performance

Shares of NYSEARCA XBI opened at $126.11 on Tuesday. SPDR S&P Biotech ETF has a 12 month low of $66.66 and a 12 month high of $132.09. The firm’s 50 day simple moving average is $124.24 and its 200-day simple moving average is $109.01. The stock has a market capitalization of $8.43 billion, a price-to-earnings ratio of 11.47 and a beta of 0.93.

SPDR S&P Biotech ETF Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges. The Biotech Index is a modified equal weight index.